Ameriprise’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$49.4M Sell
185,303
-51,368
-22% -$13.9M 0.01% 877
2025
Q4
$59.4M Sell
236,671
-22,149
-9% -$5.88M 0.01% 788
2025
Q3
$74.3M Buy
258,820
+13,951
+6% +$3.74M 0.02% 685
2025
Q2
$64.3M Buy
244,869
+40,016
+20% +$9.74M 0.02% 737
2025
Q1
$47.7M Buy
204,853
+11,479
+6% +$2.79M 0.01% 865
2024
Q4
$44.3M Sell
193,374
-7,564
-4% -$1.74M 0.01% 901
2024
Q3
$44.9M Sell
200,938
-13,144
-6% -$2.89M 0.01% 891
2024
Q2
$43.6M Buy
214,082
+22,613
+12% +$4.6M 0.01% 860
2024
Q1
$41.8M Sell
191,469
-376,176
-66% -$82.9M 0.01% 892
2023
Q4
$129M Buy
567,645
+27,216
+5% +$5.72M 0.04% 436
2023
Q3
$109M Buy
540,429
+441,527
+446% +$93.1M 0.04% 464
2023
Q2
$20.5M Buy
98,902
+9,194
+10% +$1.78M 0.01% 1243
2023
Q1
$17.7M Sell
89,708
-1,589
-2% -$327K 0.01% 1346
2022
Q4
$18.5M Sell
91,297
-21,525
-19% -$4.21M 0.01% 1272
2022
Q3
$20.1M Sell
112,822
-17,250
-13% -$3.53M 0.01% 1179
2022
Q2
$25.8M Buy
130,072
+129
+0.1% +$27.5K 0.01% 1043
2022
Q1
$28.6M Buy
129,943
+30,194
+30% +$7.1M 0.01% 1098
2021
Q4
$26.8M Buy
99,749
+12,519
+14% +$3.1M 0.01% 1204
2021
Q3
$21.1M Sell
87,230
-30,557
-26% -$7.7M 0.01% 1223
2021
Q2
$27.9M Buy
117,787
+2,684
+2% +$612K 0.01% 1116
2021
Q1
$25.2M Buy
115,103
+4,242
+4% +$851K 0.01% 1154
2020
Q4
$19.4M Sell
110,861
-140,548
-56% -$24.3M 0.01% 1246
2020
Q3
$40.7M Sell
251,409
-8,963
-3% -$1.42M 0.02% 718
2020
Q2
$37.2M Buy
260,372
+351
+0.1% +$48.6K 0.02% 735
2020
Q1
$28.2M Sell
260,021
-1,296
-0.5% -$187K 0.01% 772
2019
Q4
$38M Sell
261,317
-341,661
-57% -$49.3M 0.02% 823
2019
Q3
$87M Sell
602,978
-6,627
-1% -$967K 0.04% 451
2019
Q2
$90.6M Sell
609,605
-61,746
-9% -$8.62M 0.04% 452
2019
Q1
$88.2M Buy
671,351
+437,238
+187% +$53.9M 0.04% 448
2018
Q4
$25.4M Sell
234,113
-107,789
-32% -$14.4M 0.01% 924
2018
Q3
$51M Buy
341,902
+38,737
+13% +$5.89M 0.02% 745
2018
Q2
$46.8M Buy
303,165
+205,533
+211% +$31M 0.02% 705
2018
Q1
$13.6M Sell
97,632
-17,739
-15% -$2.61M 0.01% 1410
2017
Q4
$15.8M Buy
115,371
+12,668
+12% +$1.67M 0.01% 1246
2017
Q3
$13.3M Sell
102,703
-44,780
-30% -$5.97M 0.01% 1352
2017
Q2
$19.5M Sell
147,483
-189,244
-56% -$23.2M 0.01% 1039
2017
Q1
$41.5M Sell
336,727
-8,093
-2% -$958K 0.02% 615
2016
Q4
$38M Sell
344,820
-141,172
-29% -$15.7M 0.02% 625
2016
Q3
$57.4M Sell
485,992
-20,088
-4% -$2.37M 0.03% 460
2016
Q2
$56.6M Sell
506,080
-582,544
-54% -$62.7M 0.03% 442
2016
Q1
$110M Buy
1,088,624
+154,704
+17% +$14.8M 0.07% 287
2015
Q4
$99.2M Buy
933,920
+189,445
+25% +$19.5M 0.06% 306
2015
Q3
$69.4M Sell
744,475
-1,218
-0.2% -$126K 0.04% 371
2015
Q2
$77.7M Buy
745,693
+39,137
+6% +$4.07M 0.04% 373
2015
Q1
$76.6M Buy
706,556
+666,113
+1,647% +$68.5M 0.04% 390
2014
Q4
$3.75M Buy
40,443
+1,723
+4% +$152K ﹤0.01% 2231
2014
Q3
$3.38M Sell
38,720
-328
-0.8% -$29.6K ﹤0.01% 2263
2014
Q2
$3.44M Sell
39,048
-5,155
-12% -$447K ﹤0.01% 2301
2014
Q1
$3.73M Sell
44,203
-786
-2% -$62.7K ﹤0.01% 2208
2013
Q4
$3.53M Sell
44,989
-3,921
-8% -$334K ﹤0.01% 2203
2013
Q3
$4.17M Buy
48,910
+7,310
+18% +$616K ﹤0.01% 2058
2013
Q2
$3.58M Buy
+41,600
New +$3.45M ﹤0.01% 2066

Other funds holding LH

Ameriprise's LH Position: Q1 2026 in Review

Ameriprise reduced its Labcorp (LH) stake by 22% in Q1 2026, selling an estimated $13.9M and leaving 185,303 shares worth $49.4M. The position accounts for 0.01% of the portfolio, ranked #877.

Ameriprise first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $129M in Q4 2023. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Ameriprise held 185,303 shares of Labcorp worth $49.4M as of Q1 2026.
  • Ameriprise sold 51,368 Labcorp shares in Q1 2026, an estimated $13.9M.
  • Labcorp made up 0.01% of Ameriprise's portfolio in Q1 2026, its #877 holding.
  • Ameriprise first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Ameriprise's Labcorp position peaked at $129M in Q4 2023.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.